Last updated: March 20, 2017
Sponsor: Beth Israel Deaconess Medical Center
Overall Status: Terminated
Phase
3
Condition
Lung Cancer
Non-small Cell Lung Cancer
Arrhythmia
Treatment
N/AClinical Study ID
NCT00300495
2005P000376
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Resectable lung nodule or mass
Exclusion
Exclusion Criteria:
Allergy to amiodarone
Currently taking amiodarone
Documented atrial fibrillation within past 12 months
Known pulmonary fibrosis
Known hepatic dysfunction
Thyroid disease
2nd or 3rd degree heart block
Severe SA node disease
Bradycardia-induced syncope
Pregnancy
Study Design
Total Participants: 19
Study Start date:
February 01, 2006
Estimated Completion Date:
October 13, 2009
Study Description
Connect with a study center
Beth Israel Deaconess Medical Center
Boston, Massachusetts 02215
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.